EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation

Christophe Masset, Benoit Mesnard, Olivia Rousseau, Alexandre Walencik, Ismaël Chelghaf, Magali Giral, Aurélie Houzet, Gilles Blancho, Jacques Dantal, Julien Branchereau, Claire Garandeau, Diego Cantarovich

Transplant International · 2025

DOI: 10.3389/ti.2025.14026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2025. Verfasst von Christophe Masset und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France. Hauptthemen laut MEDLINE: Pancreas Transplantation, Kidney Transplantation, Etanercept, Graft Rejection. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rate of early pancreas allograft failure remains high due to thrombosis but also to severity of rejection episodes. We investigated if adjunct anti-TNFα therapy was safe and could improve outcomes after pancreas transplantation. We investigated all pancreas transplants performed in our institution between 2010 and 2022. Etanercept, an anti TNFα therapy, was added to our standard immunosuppressive regimen since 2017 after approval from our institutional human ethics committee. Pancreas survival, rejection episodes, as well as infectious complications were analyzed. A total of 236 pancreas transplants were included, among whom 87 received Etanercept for induction. In multivariable analysis, after adjustment on confounding variables, pancreas survival did not differ between groups (HR = 0.92, CI 95% = 0.48; 1.73, p = 0.79). However, patients receiving Etanercept presented a significantly lower occurrence of pancreas rejection in multivariate analysis (HR = 0.36, CI 95% = 0.14; 0.95, p = 0.04). Patients receiving Etanercept did not experienced a higher risk of bacterial, fungal, CMV nor BK virus infections compared to the non-treated group. The use of anti-TNFα after pancreas transplantation was safe and did not increase infectious complications. Despite a similar rate of thrombosis, anti-TNFα significantly reduced pancreatic rejection, thus supporting its use among pancreas transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreas TransplantationKidney TransplantationEtanerceptGraft RejectionTumor Necrosis Factor-alphaImmunosuppressive AgentsHumansMaleFemaleMiddle AgedAdultGraft SurvivalRetrospective StudiesTreatment OutcomePostoperative Complications

Stichwörter der Autor:innen

allograft rejectionallograft thrombosisanti-TNFαinflammationischemia/reperfusionpancreas transplantation

Substanzen

EtanerceptTumor Necrosis Factor-alphaImmunosuppressive Agents

Autor:innen und Institutionen

  • Institut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
  • Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
  • Laboratoire Human Leucocyte Antigen (HLA), Etablissement Français du Sang, Nantes, France.

Zitieren

APA

Masset, C., Mesnard, B., Rousseau, O., Walencik, A., Chelghaf, I., Giral, M., Houzet, A., Blancho, G., Dantal, J., Branchereau, J., Garandeau, C., & Cantarovich, D. (2025). Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation. Transplant International. https://doi.org/10.3389/ti.2025.14026

Vancouver

Masset C, Mesnard B, Rousseau O, Walencik A, Chelghaf I, Giral M, et al. Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation. Transplant International. 2025. doi:10.3389/ti.2025.14026

BibTeX
@article{Masset2025,
  author = {Masset, Christophe and Mesnard, Benoit and Rousseau, Olivia and Walencik, Alexandre and Chelghaf, Ismaël and Giral, Magali and Houzet, Aurélie and Blancho, Gilles and Dantal, Jacques and Branchereau, Julien and Garandeau, Claire and Cantarovich, Diego},
  title = {Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14026}
}
Kostenlos starten →